ClinicalTrials.Veeva

Menu

Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection

O

Ospedale Generale Di Zona Moriggia-Pelascini

Status

Completed

Conditions

COVID-19
Sars-CoV-2 Infection

Study type

Observational

Funder types

Other

Identifiers

NCT05143320
NPS impairment in Covid-19

Details and patient eligibility

About

Recent studies suggest cognitive, emotional and behavioural impairments occur in patients after SARS-CoV-2 infection. Problems with memory, attention, information processing and executive functions are particularly prevalent in these patients, probably due to hypothesised sensitivity of the hippocampus to the virus. Cognitive impairment is also present in patients with no neurological, neuropsychological and neuropsychiatric history. Therefore, the aim of the present study is to describe neuropsychological and neuropsychiatric features in patients recovered from moderate to severe forms of Covid-19 some weeks after hospital dismission.

Enrollment

29 patients

Sex

All

Ages

30 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Positive PCR from nasopharyngeal swab
  • No ICU admission

Exclusion criteria

  • Diagnosis of neurologic or psychiatric disorders;
  • Previous cognitive impairment;
  • Other medical conditions negatively affecting the cognitive status.

Trial design

29 participants in 2 patient groups

Covid+
Covid-

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems